4//SEC Filing
Hochman David P 4
Accession 0001104659-24-103002
CIK 0001814114other
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 8:15 AM ET
Size
14.5 KB
Accession
0001104659-24-103002
Insider Transaction Report
Form 4
Hochman David P
DirectorSee Remarks
Transactions
- Purchase
Common Stock, par value $0.0001 per share ("Common Stock")
2024-09-24$4.91/sh+2,500$12,275→ 570,498 total - Purchase
Common Stock
2024-09-25$4.86/sh+1,500$7,290→ 335,002 total(indirect: By Trust) - Purchase
Common Stock
2024-09-25$4.74/sh+2,000$9,480→ 2,000 total(indirect: By Trust) - Purchase
Common Stock
2024-09-25$4.70/sh+2,000$9,400→ 2,000 total(indirect: By Trust) - Purchase
Common Stock
2024-09-25$4.73/sh+2,000$9,460→ 2,000 total(indirect: By Trust)
Holdings
- 3,140(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.90 to $4.95. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.83 to $4.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.72 to $4.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.77. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F5]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.72 to $4.77. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Orchestra BioMed Holdings, Inc.
CIK 0001814114
Entity typeother
Related Parties
1- filerCIK 0001292834
Filing Metadata
- Form type
- 4
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 8:15 AM ET
- Size
- 14.5 KB